Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 521 entries
View as:

Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene

Phase: N/A Priority: Normal
NCT ID: NCT01221077 Org: User:
Start: 04/08/11 End: 09/01/14 Due: 09/01/15

Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00776516 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01427387 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Phase: N/A Priority: Normal
NCT ID: NCT01737268 Org: User:
Start: 10/29/12 End: 06/29/16 Due: 06/29/17

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT02570035 Org: User:
Start: 12/31/12 End: 03/31/15 Due: 03/31/16

Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01015040 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10

A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus

Phase: N/A Priority: Normal
NCT ID: NCT01190670 Org: User:
Start: 07/31/10 End: 09/30/10 Due: 09/30/11

Optimizing Prograf® Therapy in Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00297765 Org: User:
Start: 01/31/03 End: 03/31/06 Due: 03/31/07

A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03528629 Org: User:
Start: 06/08/18 End: 06/09/20 Due: 06/09/21

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

Phase: N/A Priority: Normal
NCT ID: NCT01093534 Org: User:
Start: 01/19/10 End: 06/23/11 Due: 06/23/12

Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00157014 Org: User:
Start: 05/10/04 End: 07/18/08 Due: 07/18/09

To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects

Phase: N/A Priority: Normal
NCT ID: NCT01424332 Org: User:
Start: 12/31/07 End: 03/31/08 Due: 03/31/09

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00309088 Org: User:
Start: 04/30/06 End: 06/30/08 Due: 06/30/09

A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability

Phase: N/A Priority: Normal
NCT ID: NCT01126424 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

Reproducibility Study of Overactive Bladder Symptom Score [OABSS]

Phase: N/A Priority: Normal
NCT ID: NCT01122550 Org: User:
Start: 09/30/09 End: 08/31/10 Due: 08/31/11

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00717379 Org: User:
Start: 05/31/07 End: 10/31/08 Due: 10/31/09

Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

Phase: N/A Priority: Normal
NCT ID: NCT02586246 Org: User:
Start: 01/31/11 End: 05/31/13 Due: 05/31/14

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00801944 Org: User:
Start: 04/30/04 End: 10/31/05 Due: 10/31/06

Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03183739 Org: User:
Start: 06/20/17 End: 10/06/17 Due: 10/06/18

A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01478529 Org: User:
Start: 02/28/06 End: 03/31/06 Due: 03/31/07

A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD

Phase: N/A Priority: Normal
NCT ID: NCT00378690 Org: User:
Start: 03/31/06 End: 12/31/12 Due: 12/31/13

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00459719 Org: User:
Start: 03/31/07 End: 03/31/09 Due: 03/31/10

A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India

Phase: N/A Priority: Normal
NCT ID: NCT02432053 Org: User:
Start: 03/31/12 End: 05/31/13 Due: 05/31/14

Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01539707 Org: User:
Start: 03/13/12 End: 08/13/12 Due: 08/13/13

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00384202 Org: User:
Start: 10/31/06 End: 11/30/07 Due: 11/30/08